Therapeutic Classes/Tumor Necrosis Factor Blocker

Tumor Necrosis Factor Blocker

17 drugs across 8 manufacturers|1 Generic,16 Brand

Total Drugs

17

1G / 16B

Manufacturers

8

Avg $3616.8119/unit

Avg 7d Change

0.00%

Across 3 drugs with changes

7d Activity

2114 flat

of 17 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Drug Portfolio

17 drugs total, 17 shown

Drug Price 7d Change
SIMPONI 50 MG/0.5 ML SYRINGE
golimumab
$12977.2440
per ML
SIMPONI 50 MG/0.5 ML PEN INJEC
golimumab
$12974.5178
per ML
SIMPONI 100 MG/ML PEN INJECTOR
golimumab
$7446.2126
per ML
CIMZIA 2X200 MG/ML SYRINGE KIT
certolizumab pegol
$6112.3912
per EA
CIMZIA 2X200 MG/ML(X3)START KT
certolizumab pegol
$6072.5137
per EA
ENBREL 50 MG/ML SURECLICK
etanercept
$2083.3498
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
etanercept
$2081.5847
per ML
ENBREL 50 MG/ML SYRINGE
etanercept
$2080.7423
per ML
ENBREL 25 MG/0.5 ML SYRINGE
etanercept
$2076.2308
per ML
ADALIMUMAB-ADAZ(CF) PEN 40 MG/0.4 ML
adalimumab-adaz
$1592.1565
per ML
-0.07%
HADLIMA(CF) PUSHTOUCH 40 MG/0.4 ML
adalimumab-bwwd
$1261.5564
per ML
+0.04%
HADLIMA(CF) 40 MG/0.4 ML SYRINGE
adalimumab-bwwd
$1259.2450
per ML
+0.02%
REMICADE 100 MG VIAL
INFLIXIMAB
$1135.9660
per EA
HADLIMA PUSHTOUCH 40 MG/0.8 ML
adalimumab-bwwd
$632.2413
per ML
YUSIMRY(CF) 40 MG/0.8 ML PEN
adalimumab-aqvh
$604.1525
per ML
YUSIMRY(CF) 40 MG/0.8 ML PEN
adalimumab-aqvh
$604.1525
per ML
INFLECTRA 100 MG VIAL
infliximab-dyyb
$491.5457
per EA